We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$954M
AUM Growth
-$71.4M
Cap. Flow
-$2.48M
Cap. Flow %
-0.26%
Top 10 Hldgs %
46.58%
Holding
81
New
11
Increased
16
Reduced
19
Closed
9

Top Buys

Rank Stock Value
1
AMPH icon
Amphastar Pharmaceuticals
AMPH
+$20.6M
2
THOR
THORATEC CORPORATION
THOR
+$14.2M
3
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$13.8M
4
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$11.5M
5
KND
Kindred Healthcare
KND
+$10.8M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$19.4M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$15.5M
3
NVDQ
Novadaq Technologies Inc.
NVDQ
+$14.7M
4
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$13.5M
5
AMAG
AMAG Pharmaceuticals
AMAG
+$9.6M

Sector Composition

Rank Sector Weight
1 Healthcare 78.52%
2 Consumer Discretionary 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPCH icon
76
Option Care Health
OPCH
$3.41B
– –
-287,221
Closed -$9.58M
TEVA icon
77
PUT
Teva Pharmaceuticals
TEVA
$37.3B
– –
-4,000
Closed -$210K
SGNT
78
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-330,188
Closed -$8.54M
POZN
79
DELISTED
POZEN INC
POZN
– –
-659,730
Closed -$5.5M
CFN
80
DELISTED
CAREFUSION CORPORATION
CFN
– –
-125,000
Closed -$5.54M
AUXL
81
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-300,000
Closed -$6.02M
1 2 3
4

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Broadfin Capital held 81 positions worth $954M, down 7% from $1.03B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Broadfin Capital's Q3 2014 filing shows 11 new, 16 increased, 19 reduced and 9 closed positions. Its largest new stake was Amphastar Pharmaceuticals: 1,977,854 shares worth $23M. The largest sale was BioDelivery Sciences International, Inc., an estimated $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 80% a quarter earlier, followed by Consumer Discretionary.

  • Broadfin Capital's largest Q3 2014 buy was Amphastar Pharmaceuticals: 1,977,854 shares worth $23M.
  • Broadfin Capital added most to Progenics Pharmaceuticals Inc in Q3 2014, an estimated $11.5M increase.
  • Broadfin Capital's biggest Q3 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $19.4M.
  • Broadfin Capital fully exited Option Care Health in Q3 2014, selling an estimated $9.58M.
  • Broadfin Capital's ten largest holdings make up 47% of its $954M portfolio in Q3 2014.
  • Broadfin Capital opened 11 new positions and closed 9 in Q3 2014.
  • Broadfin Capital's portfolio value fell 7% quarter-over-quarter to $954M.

Based on Broadfin Capital's 13F filing for Q3 2014, filed 14 Nov 2014.